Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma

Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma

<strong>Background</strong> This multicentre cohort study sought to define a robust pathological indicator of clinically meaningful response to neoadjuvant chemotherapy in oesophageal adenocarcinoma. <strong>Methods</strong> A questionnaire was distributed to 11 UK upper gas...

Full description

Bibliographic Details
Main Authors:	Noble, F, Lloyd, MA, Turkington, R, Griffiths, E, O'Donovan, M, O'Neill, JR, Mercer, S, Parsons, SL, Fitzgerald, RC, Underwood, TJ, Occams Consortium
Other Authors:	Davies, J
Format:	Journal article
Language:	English
Published:	John Wiley & Sons Ltd 2017

Similar Items

Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
by: Schmidt, T, et al.
Published: (2021)

ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
by: JV Reynolds, et al.
Published: (2017-06-01)

Identifying outcomes reported in exercise interventions in oesophagogastric cancer survivors: a systematic review
by: Louise O’Connor, et al.
Published: (2021-05-01)

Outcomes after Surgical Treatment of Oesophagogastric Cancer with Synchronous Liver Metastases: A Multicentre Retrospective Cohort Study
by: Sander J. M. van Hootegem, et al.
Published: (2024-02-01)

The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
by: Michael Flynn, et al.
Published: (2018-07-01)

Laparoscopic fundoplication and new aspects of neural anatomy at the oesophagogastric junction
by: P. Gehwolf, et al.
Published: (2020-06-01)

ELEVATE – evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial
by: Elizabeth Smyth, et al.
Published: (2022-09-01)

Dashboarding for real-time analysis of oesophagogastric outcomes data
by: Ash, S, et al.
Published: (2021)

Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients
by: Shereen El Mashed, et al.
Published: (2022-08-01)

Rehabilitation strategies following oesophagogastric and Hepatopancreaticobiliary cancer (ReStOre II): a protocol for a randomized controlled trial
by: Linda O’Neill, et al.
Published: (2020-05-01)

Laparoscopic vs. open feeding jejunostomy insertion in oesophagogastric cancer
by: Sotiris Mastoridis, et al.
Published: (2021-10-01)

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction
by: Moehler Markus, et al.
Published: (2013-02-01)

Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
by: Fereshteh Izadi, et al.
Published: (2021-07-01)

Prognostic Relevance of Weight and Weight Loss during Multimodal Therapy for Oesophagogastric Tumours
by: Alessandro Lorusso, et al.
Published: (2022-04-01)

Evaluation of the Oesophagogastric Cancer-Associated Microbiome: A Systematic Review and Quality Assessment
by: Bhamini Vadhwana, et al.
Published: (2023-05-01)

Trends and variation in the management of oesophagogastric cancer patients: a population-based survey
by: Greenberg David C, et al.
Published: (2009-12-01)

Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma
by: Thomas, A, et al.
Published: (2019)

Value of individual surgeon performance metrics as quality assurance measures in oesophagogastric cancer surgery
by: A. G. M. T. Powell, et al.
Published: (2020-02-01)

A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancer
by: Nadia N. Khan, et al.
Published: (2022-02-01)

Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric Adenocarcinoma
by: Michael Davidson, et al.
Published: (2019-05-01)

Efficacy and toxicity of salvage weekly paclitaxel chemotherapy in non-Asian patients with advanced oesophagogastric adenocarcinoma
by: Noelia Tarazona, et al.
Published: (2016-03-01)

Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer.
by: Marc Abraham, et al.
Published: (2019-01-01)

The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic
by: Frankell, AM, et al.
Published: (2019)

Opposing Immune-Metabolic Signature in Visceral Versus Subcutaneous Adipose Tissue in Patients with Adenocarcinoma of the Oesophagus and the Oesophagogastric Junction
by: Aisling B. Heeran, et al.
Published: (2021-11-01)

Vitamin insufficiency after surgery for oesophagogastric neoplasms: a study protocol for a prospective intervention study
by: Ariadne L van der Velden, et al.
Published: (2023-07-01)

PD-1 blockade attenuates surgery-mediated immunosuppression and boosts Th1 immunity perioperatively in oesophagogastric junctional adenocarcinoma
by: Maria Davern, et al.
Published: (2023-06-01)

Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study
by: Fiona Turkes, et al.
Published: (2022-03-01)

Targeting Vascular Endothelial Growth Factor in Oesophagogastric Cancer: A Review of Progress to Date and Immunotherapy Combination Strategies
by: Oliver Butters, et al.
Published: (2019-07-01)

Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis.
by: Daffolyn Rachael Fels Elliott, et al.
Published: (2017-05-01)

The role of community health workers in cervical cancer screening in low-income and middle-income countries: a systematic scoping review of the literature
by: O'Donovan, J, et al.
Published: (2019)

Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis
by: Yang Yu, et al.
Published: (2022-12-01)

Surgical treatment of a circumferential oesophagogastric mass associated with a peritoneopericardial diaphragmatic hernia in a Maine Coon cat
by: Maxime G Derré, et al.
Published: (2022-05-01)

Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis
by: Emil ter Veer, et al.
Published: (2017-08-01)

Survey response rates: national and regional differences in a European multicentre study of vertebral osteoporosis.
by: O'Neill, T, et al.
Published: (1995)

Combinatorial Resistance: The Best Defense is a Good Offense
by: Kevin J O'Donovan, et al.
Published: (2013-11-01)

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
by: Secrier, M, et al.
Published: (2016)

Case study: the implementation of a data-driven industrial analytics methodology and platform for smart manufacturing
by: Peter O’Donovan, et al.
Published: (2016-12-01)

IAMM: A Maturity Model for Measuring Industrial Analytics Capabilities in Large-scale Manufacturing Facilities
by: Peter O’Donovan, et al.
Published: (2016-12-01)

Semi-embedded valve anastomosis a new anti-reflux anastomotic method after proximal gastrectomy for adenocarcinoma of the oesophagogastric junction
by: Baohua Wang, et al.
Published: (2020-10-01)

Access to healthcare for people experiencing homelessness in the UK and Ireland: a scoping review
by: Sarah McNeill, et al.
Published: (2022-07-01)